Fredrik Uhlin

Adjunct Associate Pr, Docent

Publications

2026

Emelie Laveborn, Fredrik Uhlin, Nikolaos Tzimas, Anna Warme, Ainhoa Indurain, Jan Flesche, Ellinor Bergdahl, Hans Furuland, Anders Fernström, Maria K. Svensson, Bernd Stegmayr, Michael Ott (2026)

Effect of reduced ultrafiltration rate on the cardiac biomarkers NT-proBNP and troponin T: a prospective crossover study BMC Nephrology, Vol. 27, Article 547 (Article in journal)

https://dx.doi.org/10.1186/s12882-026-05364-4

Ainhoa Indurain, Markus Karlsson, Anders Fernström, Fredrik Uhlin, Marten Segelmark, Olof Dahlqvist Leinhard (2026)

Adverse Muscle Composition Is Associated with All-Cause Mortality in CKD A UK Biobank Imaging Study American Society of Nephrology. Clinical Journal, Vol. 21, p. 972-983 (Article in journal)

https://dx.doi.org/10.2215/CJN.0000001049

Linnea Tyrberg, Fredrik Uhlin, Shanavaz Alam, Elisabeth Sonesson, Thomas Hellmark, Anna M. Blom, Marten Segelmark (2026)

Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase Clinical Kidney Journal, Vol. 19, Article sfaf393 (Article in journal)

https://dx.doi.org/10.1093/ckj/sfaf393

Ainhoa Indurain, Markus Karlsson, Anders Fernström, Fredrik Uhlin, Jennifer Linge, Mikael Petersson, Olof Dahlqvist Leinhard, Marten Segelmark (2026)

Adverse Muscle Composition Is an Early Feature of Chronic Kidney Disease and Associates With Poor Function and Comorbidities Kidney Medicine, Vol. 8, Article 101164 (Article in journal)

https://dx.doi.org/10.1016/j.xkme.2025.101164

2025

Karin Staaf, Fredrik Uhlin (2025)

The Chain of Cannulation: A Qualitative Comparison of the Cannulation Process and European Guidelines Journal of Renal Care, Vol. 51, Article e70035 (Article in journal)

https://dx.doi.org/10.1111/jorc.70035

News

Two women in hospital wear and two men talk in a corridor.

Research centre to bring hope to kidney patients

Kidney disease is more common than people realise. By 2040, kidney failure may be the fifth most common cause of death, if nothing is done. With the Ingrid Asp Kidney Research Center, LiU will drive the development of knowledge and new treatments.